ArticleScientific reports2025
Comparative assessment of annotation tools reveals critical antimicrobial resistance knowledge gaps in Klebsiella pneumoniae.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A host-encoded prophage targets a Candidate Phyla Radiation bacterium and shapes episymbiotic interactions.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- cAMRah: a scalable and portable workflow for harmonized antimicrobial resistance gene prediction from bacterial genomes.Bioinformatics advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial antimicrobial resistance (AMR) poses a significant public health threat. The increase of both global awareness and affordable whole genome sequencing has yielded an ever-growing collection of bacterial genome sequence datasets and corresponding antibiotic resistance metadata. This enables the use of computational techniques, including machine learning (ML), to predict phenotypes and discover novel AMR-associated variants. With the great variety of resistance mechanisms to interrogate and the number of datasets that can be mined, there is a need to identify where novel AMR marker discovery is most necessary. Multiple databases and annotation pipelines exist to annotate AMR variants known to be associated with resistance to specific antibiotics or antibiotic classes, however, the completeness of these databases varies, and for some antibiotics, even the most complete databases remain insufficient for accurate classification. Here, we build predictive ML models using only those known markers, which we call "minimal models" of resistance. We predict the binary resistance phenotypes of 20 major antimicrobials in the genomically diverse pathogen Klebsiella pneumoniae, allowing us to identify their shortcomings in phenotype prediction, thereby highlighting opportunities for novel marker discovery. We provide a critical review of the differences in annotation tools and databases commonly used in bacterial AMR studies, and outline guidance for the establishment of a standard dataset for the development and benchmarking of ML models of AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.